Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited
CUV · ASX

Clinuvel Pharmaceuticals Limited

AU$11.40

Price Arrow-0.19 (-1.639%)
27/10/2025 04:10:29 PM
All-CompaniesAll-ConsensusConsensus CheapGROWTH AUSHALO Balance SheetHALO Consensus ValueHALO Dividend GrowthHALO Ords+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Clinuvel Pharmaceuticals Limited Overview

CUV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About CUV

icon

Telephone

61.3.9660.4900

icon

Address

Level 11, 535 Bourke Street, Melbourne, Victoria (VIC) 3000

Description

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

CUV Price Chart

Key Stats

Market Cap

AU$565.26M

PE

17.30

EV/EBITDA

9.5

Dividends Overview

DIV Yield

0.4%

Franking

100%

Ex Dividend Date (est.)

04-Sep-25

Market Data

52 weeks range

Low 9.41 - 14.86

Trade Value (12mth)

AU$378,172.00

1 week

0%

1 month

2.3%

YTD

-3.59%

1 year

-20.28%

All time high

45.88

Key Fundamentals

EPS 3 yr Growth

70.90%

EBITDA Margin

44.70%

Operating Cashflow

$41m

Free Cash Flow Return

18.50%

ROIC

16.30%

Interest Coverage

NaN

Quick Ratio

9.30

Other Data

Shares Outstanding (Fully Diluted)

50m

HALO Sector

Healthcare

Next Company Report Date

01-Sep-26

Next Ex Dividend Date

04-Sep-25

Next Dividend Pay Date

19-Sep-25

Reporting Currency

AUD

Short Sell (% of issue)

3.77

CUV Announcements

Latest Announcements

DateAnnouncements
17 October 25
17 October 25
17 October 25
16 October 25
03 October 25

CUV Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.620.720.72locklocklock
EPS (Fully Diluted)
$locklocklocklock0.590.70.72locklocklock
Growth
%locklocklocklock46.615.51locklocklock
PE
Xlocklocklocklock34.621.117.3locklocklock
EV/EBITDA
Xlocklocklocklock21.711.89.5locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

04-Sep-25

DIV Yield

0.4%

Franking Level

100%

DPSg

0%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

9.04%

Value ($M)

55

Prior Change

0

7 Day Change

-0.20%

1 Month Change

2.60%

3 Months Change

3.30%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CUV Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Clinuvel Pharmaceuticals Limited (CUV:ASX)?
Halo FAQ
The current share price of Clinuvel Pharmaceuticals Limited (CUV:ASX) is AUD$11.40.
What is the 52-week high share price for Clinuvel Pharmaceuticals Limited (CUV:ASX)?
Halo FAQ
The 52-week high share price for Clinuvel Pharmaceuticals Limited (CUV:ASX) is AUD$14.86.
What is the 52-week low share price for Clinuvel Pharmaceuticals Limited (CUV:ASX)?
Halo FAQ
The 52-week low share price for Clinuvel Pharmaceuticals Limited (CUV:ASX) is AUD$9.41.
What is the dividend yield for Clinuvel Pharmaceuticals Limited (CUV:ASX)?
Halo FAQ
The current TTM dividend payout for Clinuvel Pharmaceuticals Limited (CUV:ASX) is 0.40.
What was Clinuvel Pharmaceuticals Limited (CUV:ASX) last dividend payment?
Halo FAQ
The last dividend payment of Clinuvel Pharmaceuticals Limited (CUV:ASX) is AUD$0.05.
What is the franking level for Clinuvel Pharmaceuticals Limited (CUV:ASX)?
Halo FAQ
Clinuvel Pharmaceuticals Limited (CUV:ASX) has a franking level of 100.00%.
In which sector is Clinuvel Pharmaceuticals Limited (CUV:ASX) classified?
Halo FAQ
Clinuvel Pharmaceuticals Limited (CUV:ASX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Clinuvel Pharmaceuticals Limited (CUV:ASX)?
Halo FAQ
The current P/E ratio for Clinuvel Pharmaceuticals Limited (CUV:ASX) is 17.30.

See beyond the curve.

One solution for research, investing and portfolio management.